Prolight Diagnostics AB (NGM:PRLD) 6-Month Price Index: 1.00 (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:PRLD Prolight Diagnostics AB NGM:PRLD
30 GF Score
Price kr19.48
! 2 Warning Signs
View Full Analysis

What is Prolight Diagnostics AB 6-Month Price Index?

Prolight Diagnostics AB NGM:PRLD -6.35% 30 6-Month Price Index is 1.00 as of Sep. 21, 2026. GuruFocus rates NGM:PRLD with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-09-21), Prolight Diagnostics AB's 6-Month Price Index is 1.00.

Prolight Diagnostics AB  (NGM:PRLD) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Prolight Diagnostics AB 6-Month Price Index Related Terms

NGM:PRLD vs ISRG, BDX, RMD: 6-Month Price Index Comparison

For the Medical Instruments & Supplies subindustry, Prolight Diagnostics AB's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NGM:PRLD
30GF Score
Prolight Diagnostics AB NGM:PRLD
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prolight Diagnostics AB  (NGM:PRLD) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 1.00 mean?
Prolight Diagnostics AB (NGM:PRLD) has a 6-Month Price Index of 1.00 as of Sep. 21, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Prolight Diagnostics AB and its competitors.
Is Prolight Diagnostics AB's 6-Month Price Index too high?
Prolight Diagnostics AB's current 6-Month Price Index is 1.00. Overall, Prolight Diagnostics AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Prolight Diagnostics AB's 6-Month Price Index compare to ISRG and BDX?
Prolight Diagnostics AB's 6-Month Price Index of 1.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Medical Devices & Instruments company?
A good 6-Month Price Index depends on the Medical Devices & Instruments industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Prolight Diagnostics AB and its competitors. Prolight Diagnostics AB's current 6-Month Price Index is 1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prolight Diagnostics AB stock overvalued right now?
Prolight Diagnostics AB (NGM:PRLD) has a current 6-Month Price Index of 1.00. The current 6-Month Price Index is 1.00. Prolight Diagnostics AB's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Prolight Diagnostics AB (NGM:PRLD), the current 6-Month Price Index is 1.00 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Prolight Diagnostics AB Business Description

Address Gasverksgatan 3A, Lund, SWE, 222 29
Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.
30GF Score

Get the complete analysis for NGM:PRLD

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr19.48
Price